ABM Q1 2026 Earnings EPS Misses Estimates as Stock Slips Slightly BUSEP Q1 2026 Earnings EPS Surges Past Estimates Stock Rises Modestly NTLA Q1 2026 Earnings NarrowerthanExpected Loss as Clinical Stage Company Focuses on Pipeline Execution CLVT Q1 2026 Earnings EPS Beat Lifts Sentiment but Revenue Uncertainty and Stock Decline Raise Caution SRPT Q1 2026 Earnings EPS Smashes Estimates by 1847 as Gene Therapy Execution Drives Profit Surprise Atkore ATKR Q1 2026 Earnings EPS Beats Estimates by 139 Amid Operational Strength